Trial intelligence / Profile preview

Magnesium sulphate for prevention of anesthesia-related intraocular pressure increase

IRCT138812013376N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of magnesium sulfate (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in intraocular pressure due to general anesthesia. Started Jul 2007; status: completed.

02

Drugs

magnesium sulfate

Beyond the preview

Go deeper on IRCT138812013376N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138812013376N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call